Belgium· BE-AMP-SAM660953-00

Comirnaty Original/Omicron BA.4-5 15 µg/dose - 15 µg/dose

A covid-19, rna-based vaccine product containing tozinameran, covid-19 mrna vaccine (nucleoside modified), registered in Belgium by BioNTech Manufacturing. The same ATC class is registered in 11 of our 19 countries.

ATC J07BN01

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about tozinameran, covid-19 mrna vaccine (nucleoside modified)Answers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Covid-19, rna-based vaccine is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BN01 (covid-19, rna-based vaccine), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
7 of them publish a price we can compare per daily dose

Search covid-19, rna-based vaccine products by name

Covid-19, rna-based vaccine · ATC J07BN01

11 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Tozinameran, COVID-19 mRNA Vaccine (nucleoside modified)
Manufacturer: BioNTech Manufacturing
Country: Belgium (BE)
ATC code: J07BN01
ATC class: Covid-19, RNA-based vaccine
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J07BN01

Covid-19, rna-based vaccine, as other registers publish it.

All covid-19, rna-based vaccine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c4ac957c-ad8b-4e00-828e-07baebd173dc
GET /v1/drugs/c4ac957c-ad8b-4e00-828e-07baebd173dc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Dispersion for injection",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Comirnaty Original/Omicron BA.4-5 15 µg/dose - 15 µg/dose",
  "name_fr": "Comirnaty Original/Omicron BA.4-5 15 µg/dose - 15 µg/dose",
  "name_nl": "Comirnaty Original/Omicron BA.4-5 15 µg/dose - 15 µg/dose",
  "amp_code": "SAM660953-00",
  "strengths": [
    "15.0000",
    "15.0000",
    "15.0000",
    "15.0000",
    "15.0000",
    "15.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Tozinameran, COVID-19 mRNA Vaccine (nucleoside modified)",
    "Famtozinameran, COVID-19 mRNA Vaccine (nucleoside modified)",
    "Sucrose"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Covid-19, RNA-based Vaccine",
  "authorisation_numbers": [
    "EU/1/20/1528/014"
  ]
}

API reference MCP server Plans

See everything about covid-19, rna-based vaccine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console